SKIN-F 22 for superfi cial remodeling of small blemishes
For lines
For lines
- Periocular
- Superficial
- Perioral
- Volume
- Cheekbones
- Nasolabial Folds
- Lips
- Marionette wrinkles
- Cheeks
- Cheeksbones
- Chin
- Mandibular line
ΠΕΡΙΟΧΕΣ ΕΦΑΡΜΟΓΗΣ
ΓΙΑΤΙ ΝΑ ΤΟ ΕΠΙΛΕΞΕΤΕ
SKIN-F® ITALFARMACIA
The products of the skin-line are produced by italfarmacia, a company specialized in the
production of medical devices for the aesthetic medicine, with 30 years of experience.
The llers Skin-F®, the newest addition to the skin- line family, have been produced to
complete the range of the treatments for the face with the possibility of soothing
wrinkles, restoring volumes and facial contouring.
production of medical devices for the aesthetic medicine, with 30 years of experience.
The llers Skin-F®, the newest addition to the skin- line family, have been produced to
complete the range of the treatments for the face with the possibility of soothing
wrinkles, restoring volumes and facial contouring.
PROPERTIES
Visco-elasticity and smoothing capability The presence of glycine and proline in
Skin-F® makes it di erent from the other types of ller. These amino acids, which are the
two most representative residues of collagen, allow an optimal viscosity giving the ller a
high capacity of tissue integration and consequent smoothing function, an elasticity such as to promote modeling of the gel and providing strong volumizing capacity.
Skin-F® makes it di erent from the other types of ller. These amino acids, which are the
two most representative residues of collagen, allow an optimal viscosity giving the ller a
high capacity of tissue integration and consequent smoothing function, an elasticity such as to promote modeling of the gel and providing strong volumizing capacity.
HIGH PURITY
Skin-F® is composed of purest hyaluronic acid of non-animal origin derived from bacteri
al fermentation (Streptococcus zooepidemicus).
al fermentation (Streptococcus zooepidemicus).
CROSS-LINK
Skin-F® consists of cross-linked high- molecular- weight hyaluronic acid with bdde,
which is found, anyway, at a very low percentage in the nished product.
which is found, anyway, at a very low percentage in the nished product.
ΒΙΒΛΙΟΓΡΑΦΙΑ
- Martine Baspeyras et al. Clinical and biometrological ecacy of a hyaluronic acid-based mesotherapy product: a randomised controlled study. Arch Dermatol Res (2013) 305:673–682 Yarnell E. Botanical medicines for the urinary tract. World J Urol 2002; 20(5) 285-293.
- Sergey Prikhnenko. Polycomponent mesotherapy formulations for the treatment of skin aging and improvement of skin quality. Clinical, Cosmetic and Investigational Dermatology 2015:8 151-157.
- Eleni Papakonstantinou, Michael Roth, George Karakiulakis. Hyaluronic acid : A key molecule in skin aging . Dermato- Endocri- nology 4:3, 253–258; July–December 2012; © 2012 LandesBioscience.
- Pierre-Antoine Deglesne. In vitro study of RRS HA injectable mesotherapy/ biorevitalization product on human skin broblasts and its clinical utilization. Clinical, Cosmetic and Investigational Dermatology 2016:9 41–53.
- Carmen Laurino, MSc, Beniamino Palmieri, MD, and Alessandro Coacci. Ecacy, Safety, and Tolerance of a New Injection Technique for High- and Low-Molec lar-Weight Hyaluronic Acid Hybrid Complexes. Eplasty. 2015 Oct 8;15:e46. eCollection 2015
